EA
41
3
AIZ
61
5
HAS
29
3
EW
55
5
MS
64
3
ALL
37
3
FE
34
4
AXP
63
3
NSC
33
6
AFL
34
6
EMR
57
7
MAT
41
2
EIX
61
8
UNH
42
6
JNPR
59
3
MSFT
55
2
VMC
41
2
URBN
67
3
KSS
36
2
PNW
55
3
EA
41
3
AIZ
61
5
HAS
29
3
EW
55
5
MS
64
3
ALL
37
3
FE
34
4
AXP
63
3
NSC
33
6
AFL
34
6
EMR
57
7
MAT
41
2
EIX
61
8
UNH
42
6
JNPR
59
3
MSFT
55
2
VMC
41
2
URBN
67
3
KSS
36
2
PNW
55
3
Financhill
Back

Paymentus Holdings 10K Form

Buy
64

PAY
Paymentus Holdings

Last Price:
$34.19
Seasonality Move:
-1.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PAY News And Ratings

See the #1 stock for the next 7 days that we like better than PAY

PAY Financial Statistics

Sales & Book Value

Annual Sales: $614.5M
Cash Flow: $-2.2M
Price / Cash Flow: 180.48
Annual Sales: $3.76
Price / Book: 9.09

Profitability

EPS (TTM): 0.32000
Net Income (TTM): $40.4M
Gross Margin: $182.3M
Return on Equity: 9.16%
Return on Assets: 7.81%

Paymentus Holdings Earnings Forecast

Key Paymentus Holdings Financial Ratios

  • The Gross Profit Margin over the past 18 years for PAY is 29.67%.
  • The Selling, General & Administrative Expenses for PAY have been equal to 19.53% of Gross Profit Margin.
  • The Research & Development expenses have been 7.20% of Revenue.
  • The Interest Expense is 0.11% of Operating Income.
  • The Net Earning history of PAY is 3.63% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 8 years.

Paymentus Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Financial Services
Sector: Financials
Current Symbol: PAY
CUSIP: 92342Y
Website: paymentus.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.31
Quick Ratio: 4.08

Price-to-Earnings

Trailing P/E Ratio: 190
Forward P/E Ratio: 59.73

PAY Technical Analysis vs Fundamental Analysis

Buy
64
Paymentus Holdings (PAY) is a Buy

Is Paymentus Holdings a Buy or a Sell?

  • Paymentus Holdings stock is rated a Buy
    The current Paymentus Holdings [PAY] share price is $34.20. The Score for PAY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.